Antiviral peptides against dengue virus

QR Code

Antiviral peptides against dengue virus

Dengue virus (DENV) poses a continuous threat to the public health of the global community with over 390 million infections and 25,000 deaths annually. The efficacy of the only licensed dengue vaccine, Dengvaxia, against all four DENV serotypes is less than desirable in real-world setting. In additi...

Full description

Bibliographic Details
Main Authors:	Lee, Michelle Felicia , Anasir, Mohd Ishtiaq, Poh, Chit Laa
Format:	Book Section
Published:	Academic Press 2022
Subjects:	RA Public aspects of medicine
Online Access:	http://eprints.sunway.edu.my/2160/

Similar Items

Development of novel antiviral peptides against dengue serotypes 1-4
by: Lee, Michelle Felicia, et al.
Published: (2023)

Molecular Mechanisms of Antiviral Agents against Dengue Virus
by: Lee, Michelle Felicia, et al.
Published: (2023)

Innate and adaptive immune evasion by dengue virus
by: Lee, Michelle Felicia *, et al.
Published: (2022)

Structure-based design of antivirals against Envelope Glycoprotein of dengue virus
by: Anasir, M. I. *, et al.
Published: (2020)

Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Cloning and expression of prM and it's use to distinguish host immune responses against dengue virus and Japanese encephalitis virus infections
by: Wang, Seok Mui
Published: (2001)

Development of dengue vaccines
by: Lim, Chee Siean *, et al.
Published: (2018)

Peptides as therapeutic agents for dengue virus
by: Chew, Miaw Fang *, et al.
Published: (2017)

Development of Next Generation Vaccines against SARS-CoV-2 and Variants of Concern
by: Abdul Aziz, Al-Fattah Yahaya *, et al.
Published: (2023)

Birdcages source of dengue virus
by: Medical, Xpress
Published: (2016)

Antiviral activity of silymarin in comparison with baicalein against EV-A71
by: Lalani, S.*, et al.
Published: (2020)

Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting
by: Lim, Hui Xuan *, et al.
Published: (2022)

In silico analysis for discovery of dengue virus inhibitor from natural compounds
by: Roney, Miah, et al.
Published: (2022)

Development of antivirals and vaccines against enterovirus 71 (EV-A71)
by: Poh, Chit Laa *
Published: (2018)

Strategies to improve the physicochemical properties of peptide‑based drugs
by: Lee, Michelle Felicia *, et al.
Published: (2023)

Development of single chain variable fragment antibodies against dengue virus
by: Leong, Yee Wei.
Published: (2006)

Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials
by: Lim, Hui Xuan *, et al.
Published: (2021)

Role of microRNAs in antiviral responses to dengue infection
by: Wong, Rui Rui, et al.
Published: (2020)

Predictors for early detection of severe Dengue with shock / Quah Chai Hoong
by: Quah, Chai Hoong
Published: (2019)

Development of peptide vaccines in dengue
by: Reginald, Kavita*, et al.
Published: (2017)

In-silico design of curcumin analogs as potential inhibitors of dengue virus NS2B/NS3 protease
by: Roney, Miah, et al.
Published: (2023)

The Predictive And Diagnostic Accuracy Of Pentraxin-3 And Vascular Endothelial Growth Factor In Severe Dengue
by: Low, Gary Kim Kuan
Published: (2019)

The conserved molecular determinants of virulence in dengue virus
by: Zuleeza A,, et al.
Published: (2019)

C-reactive protein : determinant value predicting length of stay in dengue patient attending emergency department HUSM Kubang Kerian
by: Md Supian, Badrul Hisham
Published: (2015)

Risk factors associated with development of dengue haemorrhagic fever or dengue shock syndrome in adults in Hospital Tengku Ampuan Afzan Kuantan
by: Tee, H. P., et al.
Published: (2009)

How to cope with dengue in the developing countries like Pakistan?
by: Sohail, Filza, et al.
Published: (2011)

Development of novel miRNA-based vaccines and antivirals against Enterovirus 71
by: Yee, Isabel Pin Tsin *, et al.
Published: (2016)

Evaluation for antiviral potential of ficus deltoidea against dengue virus type-2
by: Yuan, Seng Wu, et al.
Published: (2024)

Computational evaluation of quinones of Nigella sativa L. as potential inhibitor of dengue virus NS5
by: Roney, Miah, et al.
Published: (2023)

Functional insights into Silymarin as an antiviral agent against Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2021)

Two-mode network modeling and analysis of dengue epidemic behaviour in Gombak, Malaysia
by: Malik, Hafiz Abid Mahmood, et al.
Published: (2017)

We need a national plan to combat dengue
by: Gazali, Ahmad Mahfuz
Published: (2023)

The effectiveness of diphenyltin (IV) and triphenyltin (IV) alkylphenyldithiocarbamate compounds as insecticide against aedes aegypti LINN. (Diptera: Culicidae) in laboratory
by: Normah Awang,, et al.
Published: (2014)

Preliminary screening of potential antiviral peptide targeting EV71 virus particles using phage display peptide library
by: Tan, Sin Shen
Published: (2010)

A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19
by: Ahmed, Shabina Ishtiaq, et al.
Published: (2023)

Inhibition of Enterovirus 71 (EV-71 infections by a novel antiviral peptide derived from EV-71 capsid protein VP1
by: Tan, Chee Wah, et al.
Published: (2012)

Kesan akut kafein ke atas penggunaan oksigen dan tanggapan tahap lesu semasa senaman intensiti sederhana dalam kalangan dewasa muda perempuan yang sedentari
by: Szu Meng, Lee, et al.
Published: (2013)

Structural vaccinology for viral vaccine design
by: Mohd Ishtiaq Anasir, *, et al.
Published: (2019)

Flavonoids as antiviral agents for Enterovirus A71 (EV-A71)
by: Lalani, S.*, et al.
Published: (2020)

The effect of hydrocotyle sibthorpioides lam. extract on dengue virus 2 inhibition in vitro
by: Husin, Fitrien
Published: (2015)